搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Bacillus licheniformis Transcription elongation factor GreA (greA) CSB-YP731182BQU
CSB-EP731182BQU
CSB-BP731182BQU
CSB-MP731182BQU
CSB-EP731182BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) CSB-YP731183BQU
CSB-EP731183BQU
CSB-BP731183BQU
CSB-MP731183BQU
CSB-EP731183BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP731184BQU
CSB-EP731184BQU
CSB-BP731184BQU
CSB-MP731184BQU
CSB-EP731184BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Chaperone protein DnaK (dnaK), partial CSB-YP731185BQU
CSB-EP731185BQU
CSB-BP731185BQU
CSB-MP731185BQU
CSB-EP731185BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis UPF0365 protein BLi02729/BL01411 (BLi02729, BL01411), partial CSB-YP731186BQU1
CSB-EP731186BQU1
CSB-BP731186BQU1
CSB-MP731186BQU1
CSB-EP731186BQU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Probable glycine dehydrogenase [decarboxylating] subunit 1 (gcvPA) CSB-YP731187BQU
CSB-EP731187BQU
CSB-BP731187BQU
CSB-MP731187BQU
CSB-EP731187BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis 50S ribosomal protein L33 2 (rpmG2) CSB-YP731188BQU
CSB-EP731188BQU
CSB-BP731188BQU
CSB-MP731188BQU
CSB-EP731188BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Nucleoside diphosphate kinase (ndk) CSB-YP731189BQU
CSB-EP731189BQU
CSB-BP731189BQU
CSB-MP731189BQU
CSB-EP731189BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis 3-dehydroquinate synthase (aroB) CSB-YP731190BQU
CSB-EP731190BQU
CSB-BP731190BQU
CSB-MP731190BQU
CSB-EP731190BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Tryptophan synthase alpha chain (trpA) CSB-YP731191BQU
CSB-EP731191BQU
CSB-BP731191BQU
CSB-MP731191BQU
CSB-EP731191BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Methylglyoxal synthase (mgsA) CSB-YP731192BQU
CSB-EP731192BQU
CSB-BP731192BQU
CSB-MP731192BQU
CSB-EP731192BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis UPF0398 protein BLi02355/BL05236 (BLi02355, BL05236) CSB-YP731193BQU
CSB-EP731193BQU
CSB-BP731193BQU
CSB-MP731193BQU
CSB-EP731193BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Dihydroxy-acid dehydratase (ilvD), partial CSB-YP731194BQU
CSB-EP731194BQU
CSB-BP731194BQU
CSB-MP731194BQU
CSB-EP731194BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Methylmalonate semialdehyde dehydrogenase [acylating] 1 (iolA1) CSB-YP731195BQU
CSB-EP731195BQU
CSB-BP731195BQU
CSB-MP731195BQU
CSB-EP731195BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis DNA mismatch repair protein mutL (mutL), partial CSB-YP731196BQU
CSB-EP731196BQU
CSB-BP731196BQU
CSB-MP731196BQU
CSB-EP731196BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Protein RecA (recA) CSB-YP731197BQU
CSB-EP731197BQU
CSB-BP731197BQU
CSB-MP731197BQU
CSB-EP731197BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis 30S ribosomal protein S2 (rpsB) CSB-YP731198BQU
CSB-EP731198BQU
CSB-BP731198BQU
CSB-MP731198BQU
CSB-EP731198BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis ATP-dependent protease subunit ClpQ (clpQ) CSB-YP731199BQU
CSB-EP731199BQU
CSB-BP731199BQU
CSB-MP731199BQU
CSB-EP731199BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis tRNA (guanine-N (1)-)-methyltransferase (trmD) CSB-YP731200BQU
CSB-EP731200BQU
CSB-BP731200BQU
CSB-MP731200BQU
CSB-EP731200BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus licheniformis Acyl carrier protein (acpP) CSB-YP731201BQU
CSB-EP731201BQU
CSB-BP731201BQU
CSB-MP731201BQU
CSB-EP731201BQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>